Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial

Joana C. Barbosa, Ítala C. Silva, Tânia Caetano, Eva Mösker, Maria Seidel, Joana Lourenço, Roderich D. Süssmuth, Nuno C. Santos, Sónia Gonçalves, Sónia Mendo*

*Autor correspondente para este trabalho

Resultado de pesquisarevisão de pares

2 Citações (Scopus)


Lantibiotics are a promising class of natural antimicrobial peptides. Lichenicidin is a two-peptide lantibiotic in which two mature peptides act synergistically to exhibit full bioactivity. Considering the two-peptide lantibiotics described so far, only cytolysin has been deeply characterized in terms of toxicity towards eukaryotic cells and it was found to be hemolytic and cytotoxic. This work aimed to improve the production of lichenicidin in vivo and characterize its antibacterial activity and toxicity against human cells. Peptides were purified and minimal inhibitory concentration (MIC) was determined against several strains; a time-kill assay was performed with Staphylococcus aureus. The hemolytic effect of lichenicidin was evaluated on blood samples from healthy donors and its toxicity towards human fibroblasts. The quantity of purified peptides was 1 mg/l Bliα and 0.4 mg/l Bliβ. MIC for methicillin-sensitive and resistant S. aureus (MSSA and MRSA) strains were 16–32 µg/ml and 64–128 µg/ml, respectively. At the MIC, lichenicidin took less than 3 h to eliminate MSSA, indicating a strong bactericidal effect. It induces cell lysis at the highest concentration, an effect that might be potentiated by Bliβ. Lichenicidin was not cytotoxic to human erythrocytes and fibroblasts. In this work, we evaluated the therapeutic potential of lichenicidin as a possible antimicrobial alternative.
Idioma originalEnglish
Número do artigo18
RevistaWorld Journal of Microbiology and Biotechnology
Número de emissão1
Estado da publicaçãoPublicado - jan 2022
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial“. Em conjunto formam uma impressão digital única.